- Home
- FSEA vs GNTA Comparison
FSEA vs GNTA Comparison
Compare FSEA & GNTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FSEA
- GNTA
- Stock Information
- Founded
- FSEA 1890
- GNTA 2014
- Country
- FSEA United States
- GNTA Italy
- Employees
- FSEA N/A
- GNTA N/A
- Industry
- FSEA Savings Institutions
- GNTA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- FSEA Finance
- GNTA Health Care
- Exchange
- FSEA Nasdaq
- GNTA Nasdaq
- Market Cap
- FSEA 53.7M
- GNTA 59.7M
- IPO Year
- FSEA N/A
- GNTA 2021
- Fundamental
- Price
- FSEA $11.57
- GNTA $3.23
- Analyst Decision
- FSEA
- GNTA
- Analyst Count
- FSEA 0
- GNTA 0
- Target Price
- FSEA N/A
- GNTA N/A
- AVG Volume (30 Days)
- FSEA 4.9K
- GNTA 14.3K
- Earning Date
- FSEA 11-07-2025
- GNTA 01-01-0001
- Dividend Yield
- FSEA N/A
- GNTA N/A
- EPS Growth
- FSEA N/A
- GNTA N/A
- EPS
- FSEA N/A
- GNTA N/A
- Revenue
- FSEA $14,095,000.00
- GNTA N/A
- Revenue This Year
- FSEA N/A
- GNTA N/A
- Revenue Next Year
- FSEA N/A
- GNTA N/A
- P/E Ratio
- FSEA N/A
- GNTA N/A
- Revenue Growth
- FSEA 30.26
- GNTA N/A
- 52 Week Low
- FSEA $8.90
- GNTA $2.56
- 52 Week High
- FSEA $11.95
- GNTA $7.28
- Technical
- Relative Strength Index (RSI)
- FSEA 52.63
- GNTA 49.34
- Support Level
- FSEA $11.46
- GNTA $2.99
- Resistance Level
- FSEA $11.60
- GNTA $3.22
- Average True Range (ATR)
- FSEA 0.10
- GNTA 0.22
- MACD
- FSEA -0.00
- GNTA 0.04
- Stochastic Oscillator
- FSEA 33.31
- GNTA 71.48
About FSEA First Seacoast Bancorp Inc.
First Seacoast Bancorp Inc is a savings and loan holding company. Its business consists of taking deposits from the general public and investing those deposits, together with funds generated from operations and borrowings from the Federal Home Loan Bank, in one-to-four-family residential real estate loans, commercial real estate, and multi-family real estate loans, acquisition, development and land loans, commercial and industrial loans, home equity loans and lines of credit and consumer loans. The company generates revenue from financial instruments, such as loans, letters of credit, and investment securities, as well as revenue related to mortgage servicing activities, and bank-owned life insurance.
About GNTA Genenta Science S.p.A.
Genenta Science SPA is a clinical-stage biotechnology company engaged in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors and cancer. The company's products include Temferon - a product to treat glioblastoma multiforme, a solid tumor affecting the brain.